3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colonic Neoplasms
3
Breast Neoplasms
3
Motor Activity
2
Leiomyoma
2
Warts
1
Stomach Neoplasms
1
Psychological Well-Being
1
Psoriasis
1
Prostatic Neoplasms
1
Osteoporosis
1
Osteoarthritis
1
Obesity
1
Nasopharyngeal Neoplasms
1
Lung Neoplasms
1
Inflammation
1
Helicobacter Infections
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Chemotherapy-Related Cognitive Impairment
1
Carcinoma, Squamous Cell
1
Carcinoma, Basal Cell
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Interventions
Magnetic Resonance Spectroscopy
10
trametinib
7
Nivolumab
7
selpercatinib
6
pembrolizumab
6
dabrafenib
6
Iodine-131
6
Specimen Handling
5
Biopsy
5
lenvatinib
4
Vemurafenib
4
Iodine-124
4
durvalumab
3
cabozantinib
3
binimetinib
3
Ipilimumab
3
Immunoglobulin G
3
Fluorodeoxyglucose F18
3
Disulfides
3
Cyclophosphamide
3
Cetuximab
3
vandetanib
2
ulixertinib
2
omipalisib
2
larotrectinib
2
defactinib
2
copanlisib
2
cemiplimab
2
anlotinib
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Vitamin D
×
1 year
×
Clear all
No trials found.